Citation Impact
Citing Papers
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Ensuring Quality Cancer Care
1999
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Sarcoma and Skin Radiation Oncology
2006
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites
1988
Testicular Germ-Cell Cancer
1997 Standout
Centralised treatment, entry to trials and survival
1994
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Is local recurrence of minor importance for metastases in soft tissue sarcoma?
1991
Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity
1994 StandoutNobel
Internal validation of predictive models
2001 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites
1988
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Surgeon Volume and Operative Mortality in the United States
2003 Standout
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
2000
A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma
2008 Standout
Postchemotherapy residual masses in germ cell tumor patients
1998
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
1995
Biology of Natural Killer Cells
1989 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
A comparison of staging systems for localized extremity soft tissue sarcoma
2000
Tolerance of normal tissue to therapeutic irradiation
1991 Standout
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
2003 Standout
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1994
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
1998 Standout
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Assessing the Performance of Prediction Models
2009 Standout
Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas
1996
Adjuvant Epirubicin With or Without Ifosfamide for Adult Soft-Tissue Sarcoma
2002
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
2005
Management of soft tissue sarcomas of the extremities
2004
Characteristics of interferon induced tryptophan metabolism in human cells in vitro
1989
HNF-4 increases activity of the rat Apo A1 gene
1993
Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts
1995
A census of human cancer genes
2004 Standout
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.
1989
Quantifying heterogeneity in a meta‐analysis
2002 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
2012 Standout
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Prostatic Specific Antigen
1994
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
1995
Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
1989
The cancer genome
2009 StandoutNature
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
2016 Standout
Specificity of cell‐mediated cytotoxicity against human melanoma lines: Evidence for “non‐specific” killing by activated T‐cells
1975
Reactivity of lymphocytes from normal persons on cultured tumor cells.
1973
The Three Es of Cancer Immunoediting
2004 Standout
Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.
1981
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
2016 Standout
The Tumor Dormant State
1981
Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas
1981 Standout
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
Radiation-induced heart disease: An update
1984
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor
1975 StandoutNobel
Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
2008 Standout
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1991 Standout
Lymphocyte Mediated Cytotoxicity in Vitro. Induction and Inhibition by Humoral Antibody and Nature of Effector Cells
1972
Correlation Among Host Immunocompetence and Tumor Stage, Tumor Grade and Vascular Permeation in Transitional Carcinoma
1973
Transforming activity of human tumor DNAs.
1981
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
1982 Standout
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1991
The pathogenesis of cancer metastasis
1980 StandoutNature
Natural Cell-Mediated Immunity
1978
Adjuvant Therapy Of Soft-Tissue Sarcomas
1995
In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus.
1977 StandoutNobel
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1995
Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer
1999
Cell-Mediated Immunity to Tumor Cells
1974
Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil
1998 StandoutNobel
Prostate-specific antigen: biochemistry, analytical methods, and clinical application
1993
Postchemotherapy Retroperitoneal Surgery Remains Necessary in Patients With Nonseminomatous Testicular Cancer and Minimal Residual Tumor Masses
2003
Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis.
1999
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
1976 Standout
Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer
1994 Standout
Hospital and Physician Volume or Specialization and Outcomes in Cancer Treatment: Importance in Quality of Cancer Care
2000
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
The Treatment of Soft-tissue Sarcomas of the Extremities
1982 Standout
Detection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer
1997
In vitro „education” on autologous human sarcoma generates non‐specific killer cells
1975
Stereoselective synthesis of the C-analogue of β-d-glucopyranosyl serine
1997 StandoutNobel
Works of B Unsgaard being referenced
Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.
1984
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
1991
Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.
1989
A method for in vivo analysis of platinum after chemotherapy: with cisplatin
1988
Effects on the Cardiovascular System of Irradiation for Malignant Lymphoma
1976
Studies on the Effect of Aspiration Biopsy on the Viability of Aspirated Cells.
1964
Determination of prostate-specific antigen in serum by immunoradiometric assay
1990
Cellular immunity to human urinary bladder carcinoma. II. Effect of surgery and preoperative irradiation
1972
Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy
1972
Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
1972
Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma
1978